Pancreatic ductal adenocarcinoma (PDAC) is among the most deadly types of malignancies because of its high ability to metastasize. PDAC is thought to be under hypoxic condition. Therefore, to investigate the mechanism of metastatic processes, chronic-hypoxia-resistant PDAC cells were newly generated under hypoxic condition for 3-6 months and reoxygenation experiments were performed using these chronic-hypoxia-resistant PDAC cells in in vivo-mimicking conditions. Proliferation, invasiveness and tumorigenicity in PDAC cells were significantly increased by reoxygenation. A Hedgehog (Hh) signaling component, Gli1, was significantly increased by reoxygenation. Gli1 knockdown inhibited reoxygenation-induced increases in proliferation and tumorigenicity and decreased invasiveness through suppression of matrix metalloproteinase (MMP) 2 and MMP9. Moreover, inhibition of Sonic Hh and Smoothened abrogated reoxygenation induced increases in proliferation and invasiveness. These results suggest that metastatic processes in PDAC are induced through activation of the Hh signaling pathway. Therefore, the Hh signaling pathway may be a therapeutic target for refractory PDAC in metastatic processes induced by reoxygenation. P ancreatic ductal adenocarcinoma (PDAC) is one of the most fatal types of cancer.
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(1) Therapy with gemcitabine and tegafur ⁄ gimeracil ⁄ oteracil potassium (S-1) has demonstrated improvements in prognosis for PDAC in Japan (2) ; however, the effects are still limited. Thus, new effective therapeutic strategies for refractory PDAC are urgently required. The characteristics of invasiveness and high incidence of metastasis are among the causes of the poor prognosis of PDAC. (3) (4) (5) To complete the metastatic process, cancer cells dissolve the extracellular matrix and basal membrane, progress into adjacent tissue, intrude into lymphatic vessels, and invade blood and metastatic organs. (6) Consequently, it is important to understand the tumor microenvironment.
Tumor cells are normally located in hypoxic conditions of <1.3% O 2 .
(7) Oxygen tension is 5.3% in mixed venous blood and 3.3-7.9% in well-vascularized organs. (8) Therefore, the process by which cancer cells detach from hypoxic tumors and metastasize to secondary sites via the blood stream is thought to be reoxygenation. Some researchers have shown that malignant phenotypic changes induced by reoxygenation, such as increases in proliferation, invasiveness and tumorigenicity, occur through the MEK ⁄ ERK and PI3K ⁄ Akt signaling pathways. (9) However, the other mechanisms of phenotypic changes induced by reoxygenation remain unclear. Previously, we showed that invasiveness of PDAC cells increases under acute hypoxic conditions compared with normoxic conditions. (10) However, because cancer cells in vivo are situated in chronic hypoxic conditions, (7, (11) (12) (13) (14) to mimic and analyze in vivo local tumor sites, hypoxia-resistant tumor cells generated under chronic hypoxic conditions are required instead of tumor cells generated under normoxic or acute hypoxic conditions. We have also shown that Hedgehog (Hh) signaling plays a pivotal role in proliferation and invasiveness in PDAC cells under acute hypoxic conditions. (10) The Hh signaling pathway is crucial for the growth, patterning and morphogenesis of multiple organs during embryonic development. (15) (16) (17) Recently, it has been reported that Hh signaling is reactivated in various kinds of cancer, and, therefore, it may be a therapeutic target for cancer therapy. (18) (19) (20) (21) (22) (23) Of the Hh-related molecules, Gli1 is an activator of target genes and is itself a transcriptional target of the Hh pathway. (15, 24, 25) Therefore, in this study we used Gli1 as a marker of Hh signal activation.
In the present study, to develop a new effective therapeutic strategy for refractory PDAC, especially with regard to proliferation, tumorigenicity and invasion in metastatic processes, we generated hypoxia-resistant PDAC cell lines for reoxygenation experiments focusing on the Hh signaling pathway, and investigated the mechanism of the induction of malignant phenotypes by reoxygenation.
Materials and Methods
Cell lines. PDAC cell lines (AsPC-1 and SUIT-2) were cultured in RPMI1640 (Nacalai Tesque, Kyoto, Japan) supplemented with 10% FBS (Life Technologies, Carlsbad, CA, USA), 100 U ⁄ mL penicillin (Meijiseika, Tokyo, Japan) and 100 lg ⁄ mL streptomycin (Meijiseika). For normoxic and reoxygenated conditions, cells were cultured in 5% CO 2 and 95% air. For hypoxic conditions, cells were cultured in 1% O 2 , 5% CO 2 and 94% N 2 using a multi-gas incubator (Sanyo, Tokyo, Japan). To induce hypoxia-resistant AsPC-1 and SUIT-2 cells, these lines were cultured in hypoxic conditions; surviving cells were selected through each cell passage and were cultured under hypoxia for at least 3 months and up to 6 months because these cells we used are functionally stable between 3 and 6 months from initial culture (Fig. S1) . A passage culture was performed twice a week. The culture medium used in the experiments and the passage culture was cultured in advance under hypoxia for at least 12 h before use. We named these generated cells chronic hypoxia-resistant PDAC cells (Ch-H-R cells). In proliferation, cell invasion and colony formation assays, Ch-H-R cells were trypsinized for 2 min, were spun down for 5 min after hypoxia-pretreated medium was added and were resuspended with hypoxia-pretreated medium. After cell counting, cells were re-plated to Transwell inserts and culture plates (Becton Deckinson Labware, Flanklin Lakes, NJ, USA). On reoxygenation research, Ch-H-R cells were pretreated under reoxygenated condition for fewer than 5 days. A invasive activity, one of the major malignant phenotype, kept the same level on these cells (Fig. S2) . Cell viability of Ch-H-R cells and reoxygenated Ch-H-R cells were almost over 95% and spindle-like-cell morphology was observed in Ch-H-R cells and reoxygenated Ch-H-R cells. As a control of chronic hypoxia, PDAC cells cultured in hypoxia for fewer than 5 days were named acute hypoxic (Ac-H) cells.
Cell invasion assay. The invasiveness of the cultured cells was assessed by the number of migrating cells through Matrigel-coated Transwell inserts, as described previously. (26) The upper surface of a filter (pore size, 8.0 lm; BD Biosciences, Heidelberg, Germany) was coated with basement membrane Matrigel (BD Biosciences). Cells (1.0 9 10 4 ) were re-plated to the upper chamber and incubated in a medium for 16 h. The total number of cells that had migrated to the lower side of the filter was counted using a BZ-9000 (Biorevo; Keyence, Osaka, Japan) and Hybrid cell count software (Keyence).
Soft agar colony formation assay. Cultured cells were replated at a density of 1.0 9 10 4 cells ⁄ well into six-well plates in a 0.4% agar solution. Three weeks later, the cells were stained with 0.005% crystal violet (Sigma-Aldrich, St. Louis, MO, USA) solution. Colonies were imaged and counted in the same manner as for the cell invasion assay.
RNA interference. SiRNA for Gli1 (ON-TARGETplus SMART pool, L-003896), matrix metalloproteinase (MMP2) (ON-TARGETplus SMART pool, L-005959), MMP9 (ON-TARGETplus SMART pool, L-005970), siRNA for sonic Hh (Shh) (ON-TARGETplus SMART pool, L-006036), smoothened (Smo) (ON-TARGETplus SMART pool, L-005726) and negative control siRNA (ON-TARGETplus si CONTROL nontargeting pool, D-001810) were purchased from Dharmacon (Lafayette, CO, USA) and cells were transfected for 48 h according to the manufacturer's protocol. Cell viability is almost over 95% after gene knockdown experiments.
Isolation of RNA and real-time RT-PCR. Total RNA extraction and real-time RT-PCR were performed as described previously. (10) All primer sets amplified fragments of <200-bp long. The primers sequences used were Gli1, forward, 5′-GGT-TCAAGAGCCTGGGCTGTGT-3′, and reverse, 5′-GGCAG-CATTCTCAGTGATGCTG-3′, MMP2, forward, 5′-TGATC TTGACCAGAATACCATCGA-3′, and reverse, 5′-GGCTTG CGAGGGAAGAAGTT-3′, MMP9, forward, 5′-TGGGCTAC GTGACCTATGACAT-3′, and reverse, 5′-GCCCAGCCCAC CTCCACTCCTC-3′, Smo, forward, 5′-CAGGTGGATGGG GACTCTGTGAGT-3′, and reverse, 5′-GAGTCATGACTCCT CGGATGAGG-3′, Shh, forward, 5′-GTGTACTACGAGTCCA AGGCAC-3′, and reverse, 5′-AGGAAGTCGCTGTAGAGCAG C-3′, ACTB, forward, 5′-TTGCCGACAGGATGCAGAAGGA-3′, and reverse, 5′-AGGTGGACAGCGAGGCCAGGAT-3′.
In vivo xenograft tumor model. Five-week-old female athymic nude mice (BALB ⁄ c nu ⁄ nu) were purchased from Charles River Laboratories Japan (Kanagawa, Japan) and acclimatized for 1 week. All animal procedures were approved by the Animal Care and Use Committee at Kyushu University. The cultured cells transfected with Gli1-targeting siRNA or nontargeting control siRNA, and control cells without siRNA were subcutaneously implanted into flank regions (1.0 9 10 6 cells in RPMI per mouse) of the nude mice. The tumor size was determined once or twice a week and the tumor volume was calculated with the following formula: length 9 (width) 2 9 0.5 (mm 3 ). The mice were killed when their tumor size had reached 2 cm in diameter or if the animals had become moribund during the observation period. The tumors were resected, fixed in 10% formalin and embedded in paraffin for immunohistochemistry.
Immunofluorescent staining. In immunocytochemistry, cultured cells were fixed with 4% paraformaldehyde (Nacalai Tesque) and permeabilized with 0.1% TRITON X-100 (Wako, Osaka, Japan). In immunohistochemistry, retrieval of GLI1 antigen in xenograft tumors was performed by heating tissue sections with 0.01 mol ⁄ L sodium citrate buffer (pH 6.0) at 95°C for 10 min. These samples were immersed with Blocking One Hist (Nacalai Tesque) and were incubated with a primary rabbit polyclonal antibody against hypoxia-inducible factor-1a (HIF-1a) (1:100; #3716; Cell Signaling, Danvers, MA, USA), a rabbit polyclonal antibody against MMP2 (1:200; sc-10736; Santa Cruz, Dallas, TX, USA), a rabbit polyclonal antibody against CA9 (1:1000; NB100-417, Novus Biologicals, Lyttelton, CO, USA), a goat polyclonal antibody against GLI1 (1:50; N-16; Santa Cruz) or a goat polyclonal antibody against MMP9 (1:200; sc-6840; Santa Cruz) at room temperature for 1 h, followed by secondary Alexa 488-conjugated goat anti-rabbit IgG, 488-conjugated donkey anti-goat IgG and 594-conjugated rabbit anti-goat IgG (Life Technologies), respectively. The nuclei were counterstained with DAPI (Life Technologies), and the protein expression levels were evaluated by fluorescence intensity under fluorescence microscopy (Carl Zeiss, Tokyo, Japan), as previously described. (27) Briefly, CA9, MMP9 and GLI1 were allocated to the green channel, and HIF-1a and MMP2 were allocated to the red channel, while the nucleus was assigned the blue channel to visualize DAPI fluorescence. Red and green channel intensities were plotted as a histogram along a line scan, which revealed the fluorescence intensity. Using the intensity of the nuclear rising edge (stained by DAPI) as a standard, the expression intensity of each protein in single cells was relatively evaluated at the cell's maximum diameter. b-actin was used as a positive control. Staining with secondary antibody alone was used as a negative control.
Statistical analysis. The data are presented as the means AE SD. Student's t-tests were used to compare continuous variables between two groups. P-values of <0.05 was considered statistically significant.
Results
Reoxygenation enhances the malignant potential of pancreatic ductal adenocarcinoma cells. Wild type cells, chronic hypoxiaresistant PDAC cells (Ch-H-R cells), PDAC cells cultured under acute hypoxia (Ac-H cells) and reoxygenated Ch-H-R cells were used to investigate the change of phenotypes by reoxygenation. First, we evaluated HIF-1a, well known as one of the main hypoxic transcriptional factors, and its downstream protein CA9. CA9 positive cells were counted as described in Fig. S3 . CA9 and HIF-1a were expressed in Ch-H-R cells and Ac-H cells. However, the amount of CA9 or HIF-1a positive cells in reoxygenated Ch-H-R cells was significantly lower than in Ch-H-R cells and Ac-H cells (Figs 1a,S4) , and CA9 and HIF-1a protein expression were also confirmed by western blotting analysis (Fig. S5) . Next, we examined proliferation and invasiveness, factors of malignant potential. The ability of anchorage-dependent proliferation of reoxygenated Ch-H-R cells was the highest among the four types of cells both in AsPC-1 and SUIT-2 (Fig. 1b) . Invasiveness in Ch-H-R cells was significantly higher than that in Ac-H cells, and also significantly higher in reoxygenated Ch-H-R cells than in Ch-H-R cells both in AsPC-1 and SUIT-2 (Fig. 1c) . These results suggest that reoxygenation confers a more aggressive phenotype in PDAC cells.
Reoxygenation enhances Gli1 and matrix metalloproteinase
expression. To analyze the mechanism of reoxygenation effects, we investigated the Hh signaling pathway because we previously reported it to be correlated with the augmentation of PDAC cell proliferation and invasiveness under acute hypoxia. (10) In this study, Gli1 expression was considered a valuable marker of Hh signal activation. First, we evaluated Gli1 mRNA expression; expression of Gli1 mRNA was significantly higher in Ch-H-R cells than in Ac-H cells, and also significantly higher in reoxygenated Ch-H-R cells than in Ch-H-R cells (Fig. 2a) . The amount of Gli1 positive cells in reoxygenated Ch-H-R cells was significantly higher than in Ch-H-R cells (Figs 2b,S6) , and the GLI1 protein expression was also confirmed by western blotting analysis (Fig. S7) . Next, we evaluated two matrix metalloproteinases, MMP2 and MMP9, as factors in reoxygenation-enhanced invasion. As expected, MMP2 and MMP9 mRNA expression and the ratios of positive cells were significantly increased after reoxygenation (Figs 2c,  d,S8) , and MMP2 and MMP9 protein expression were also confirmed by western blotting analysis and gelatin zymography (Fig. S9a,b) .
Augmentation of malignant potential by reoxygenation is
induced by activation of the Hedgehog signaling pathway. Next, the correlation between activation of Hh signaling and reoxygenation-induced proliferation and invasiveness was investigated. Transfection with Gli1 siRNA in reoxygenated Ch-H-R cells led to an 80-90% decrease in Gli1 mRNA expression (Fig. S10) . Gli1 siRNA-transfected reoxygenated cells showed significant decreases in anchorage-dependent proliferation and invasion (Fig. 3a,b) . To investigate the effect of MMP on invasiveness, MMP siRNA was used. MMP2 and MMP9 knockdown efficiencies were approximately 70-90 and 60-80%, respectively (Fig. S11) . The invasiveness of MMP2 and MMP9 siRNA-transfected reoxygenated Ch-H-R cells was significantly lower than that of the control cells (Fig. 3c) . MMP2 and MMP9 co-knockdown significantly inhibited invasion compared with MMP2 or MMP9 knockdown alone (Fig. 3c) . In addition, Gli1 knockdown significantly decreased the expression of MMP2 and MMP9 (Fig. 3d) . Next, to investigate whether the upregulation of Gli1 was through Hh signaling, Shh and Smo knockdown experiments were performed. Shh and Smo knockdown efficiencies were over 90% (Fig. S12) . Shh siRNA and Smo siRNA transfected-reoxygenated Ch-H-R cells showed lower anchorage-dependent proliferative (Fig. 4a,b) and invasive (Fig. 4c,d ) abilities than the control in both cell lines. These results suggest that enhanced cell proliferation and invasion by reoxygenation are induced through the activation of Hh signaling.
Reoxygenation enhances tumorigenicity by Gli1 in vivo. To confirm the observed increase in proliferation by reoxygenation in vitro, we investigated the tumorigenicity of reoxygenated Ch-H-R cells. Normal PDAC cells cultured under normoxia were used as a control in this experiment. Anchorage-independent proliferation in reoxygenated Ch-H-R cells was significantly higher than that in wild type PDAC cells (Fig. 5a ). Tumors from mice administered with reoxygenated Ch-H-R cells were significantly larger than those from mice injected with wild-type cells (Fig. 5b) . Gli1 positive cells in tumors from mice injected with reoxygenated Ch-H-R cells were significantly higher than those in the controls (Fig. 5c) . Next, the effect of Hh signaling in increased tumorigenicity by reoxygenation was examined. Anchorage-independent proliferation in Gli1 siRNA transfected-reoxygenated Ch-H-R cells was significantly lower than that in the control (Fig. 5d ) in vitro. In vivo, tumors from mice injected with Gli1 siRNAtransfected-reoxygenated Ch-H-R cells were significantly smaller than those from mice injected with control siRNAtransfected cells (Fig. 5e) . These results suggest that Gli1 plays a pivotal role in tumorigenicity in reoxygenation in vivo.
Discussion
Hypoxia and reoxygenation are critical pathophysiological conditions enhanced by blood flow during ischemia-reperfusion injury. (28) (29) (30) In vivo, local tumor cells are exposed to chronic hypoxia, but are exposed to reoxygenation during the process of invasion and metastasis, in which tumor cells infiltrate the local blood vessels and adhere to the metastatic organs such as the liver and lung. Figure S13 shows the schema of our hypothesis. In the present study, to mimic the tumor microenvironment of reoxygenation, chronic hypoxia-resistant PDAC cell lines were generated by continuous culture for 3-6 months under hypoxia because PDAC cell lines took approximately 1-2 months to adapt (Fig. S1) . We confirmed the aggressive phenotype of Ch-H-R cells (Fig. 1b,c) ; therefore, these cells were used in a reoxygenation model that mimicked in vivo conditions in this study. First, we analyzed the expression of HIF-1a, which is an important transcriptional factor for hypoxia, (31) (32) (33) (34) and its downstream protein, CA9, in wild type cells, Ac-H cells, Ch-H-R cells and reoxygenated Ch-H-R cells. Unexpectedly, the HIF-1a positive ratio in Ch-H-R cells was lower than in Ac-H cells. This result is consistent with a previous report that shows that HIF-1a levels decrease during prolonged chronic hypoxia. (35) Because the positive ratio of HIF-1a and CA9 differed between Ac-H cells and Ch-H-R cells, there should be many relationships that can be determined only by analyzing Ch-H-R cells but not Ac-H cells. Consistent with the HIF-1a results, secretion of vascular endothelial growth factor (VEGF), regulated by HIF-1a, (36, 37) in Ch-H-R cells was significantly lower than in Ac-H cells (Fig. S14) . This result may be one reason that the VEGF monoclonal antibody, bevacizumab, is not so effective for PDAC in the clinic. Importantly, although HIF-1a is thought to contribute to tumor aggressiveness, (38, 39) reoxygenated Ch-H-R cells, which have the lowest ratio of HIF-1a positive cells among Ac-H cells, Ch-H-R cells and reoxygenated Ch-H-R cells, showed the most aggressive phenotype among these three types of cells (Fig. 1b,c) . In proliferation, because HIF1a is reported to inhibit the cell cycle under hypoxia, (40) low expression of HIF-1a may lead to the high proliferative ability in the reoxygenated Ch-H-R cells. In other functions, the factors other than HIF-1a may contribute to the induction of malignant potential by reoxygenation.
Previously we showed that Hh signaling contributes to the progression of malignant potential for Ac-H cells compared with cells cultured under normoxia independent from HIF-1a expression.
(10) Therefore, we next investigated the contribution of Hh signaling on phenotypic changes by reoxygenation. Gli1 was used as a marker of Hh signal activation because it is a transcriptional factor and target gene of Hh signaling. Consistent with our previous study, (10) Gli1 expression in Ac-H cells was higher than in wild-type cells cultured under normoxia. In this study, Gli1 expression in Ch-H-R cells was higher than in Ac-H cells, and also higher in reoxygenated Ch-H-R cells than in Ch-H-R cells (Figs 2a,b, S6, S7) . Importantly, the kinetics of these Gli1 expression patterns was almost parallel with the changes of phenotype, such as proliferation and invasiveness. Moreover, inhibition of Shh and Smo abrogated the increased proliferation and invasiveness in reoxygenated Ch-H-R cells (Fig. 4) . Taken together, these data indicate that reoxygenation-related increases in aggressive phenotypes in PDAC cells may be induced through Hh signaling. However, Gli1 is downstream of several pathways. (17, 41, 42) Koga et al. (43) show that estrogen receptor a (ERa) regulates the Hh pathway through Shh induction. Nakashima et al. (44) also reveal that nuclear factor (NF)-jB contributes to Hh signaling activation through Shh activation. Other pathways and factors such as ERa and NF-jB may also contribute to the activation of Hh signaling induced by reoxygenation. Recent studies have demonstrated the important role of MMP in cancer invasion for many solid malignant tumors. (45) In particular, type IV collagenase, MMP2 and MMP9 have been well analyzed in the hypoxia-related upregulation of invasiveness in PDAC cells. (10, 46) We have focused on MMP2 and MMP9 in this study. However, there seems to be a discrepancy between invasive ability (Fig. 1) and MMP expression by zymography (Fig. S9B) . This discrepancy might be a result of the marginal difference of MMP activity being important and the MMP activation may only occur in the invasive front.
In the present study, we demonstrated for the first time that aggressive reoxygenation-induced phenotypic changes in tumors were induced by upregulation of Gli1 through activation of Hh signaling. Therefore, our results suggest that the Hh signaling pathway may be a therapeutic target for refractory PDAC cells with respect to reoxygenation-induced proliferation, tumorigenicity and invasiveness in metastatic processes, and that an Hh signaling inhibitor may be useful in PDAC treatment.
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